Risk Management Only Part Of Behind-The-Counter Orders – Von Eschenbach
This article was originally published in The Tan Sheet
Executive Summary
Enactment of legislation to strengthen FDA's post-marketing authority is not the only hurdle to clear before the agency could begin requiring behind-the-counter sales of certain nonprescription drugs, Commissioner Andrew von Eschenbach says
You may also be interested in...
FDA Reauthorization Steers Clear Of Agency’s OTC Authority, DSHEA, AER Law
The FDA reauthorization bill Congress has passed does not rock the boat on FDA's current authority over either over-the-counter switches or dietary supplements
FDA Reauthorization Steers Clear Of Agency’s OTC Authority, DSHEA, AER Law
The FDA reauthorization bill Congress has passed does not rock the boat on FDA's current authority over either over-the-counter switches or dietary supplements
FDA Reauthorization Steers Clear Of Agency’s OTC Authority, DSHEA, AER Law
The FDA reauthorization bill Congress has passed does not rock the boat on FDA's current authority over either over-the-counter switches or dietary supplements